The relevance of gastric cancer biomarkers in prognosis and pre- and post-chemotherapy in clinical practice

被引:53
作者
Abbas, Muhammad [1 ,2 ,3 ]
Habib, Murad [4 ]
Naveed, Muhammad [1 ]
Karthik, Kumaragurubaran [5 ]
Dhama, Kuldeep [6 ]
Shi, Meiqi [2 ,3 ]
Chen Dingding [1 ]
机构
[1] China Pharmaceut Univ, Dept Clin Pharm, Sch Basic Med & Clin Pharm, Sch Pharm, Nanjing 211198, Jiangsu, Peoples R China
[2] Affiliated Nanjing Med Univ, Jiangsu Canc Hosp, Dept Med Oncol, Nanjing 211198, Jiangsu, Peoples R China
[3] Jiangsu Inst Canc & Res, Nanjing 211198, Jiangsu, Peoples R China
[4] Women & Children Hosp, Dept Pediat, Abbottabad 22044, Kpk Province, Pakistan
[5] Tamil Nadu Vet & Anim Sci Univ, Cent Univ Lab, Chennai 600051, Tamil Nadu, India
[6] ICAR Indian Vet Res Inst, Div Pathol, Izatnagar 243122, Uttar Pradesh, India
关键词
Stomach cancer; Gastric tumor markers; Biomarker; Pre- and post-chemotherapy; Diagnosis; Prognosis; Treatment; Clinical significance; PREOPERATIVE SERUM-LEVELS; CARCINOEMBRYONIC ANTIGEN CEA; GROWTH-FACTOR RECEPTORS; TUMOR-MARKERS; CA; 72-4; MICROSATELLITE INSTABILITY; MICRORNA EXPRESSION; CELL-PROLIFERATION; POOR-PROGNOSIS; P53; EXPRESSION;
D O I
10.1016/j.biopha.2017.09.032
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Gastric cancer (GC) is one among the major cancer types, causing human deaths and present noticeable heterogeneity. The incidences and mortality rates are higher in males in comparison to females with a male to female ratio of 2.3: 1. A lot of studies have revealed out the molecular basis, pathogenesis, invasion and metastasis related findings of gastric stomach cancer. Present review encompasses the salient information on various biomarkers for the early diagnosis, treatment and prognosis of gastric cancer elaborate the clinical importance of serum tumor markers in patients with this cancer as well as checking the growths, together with epigenetic changes and genetic polymorphisms. A deep and rigorous search was carried out in Pub Med/MEDLINE using specific key words; "gastric cancer", with "tumor marker". Our search yielded 4947 important reports about related topic from books and articles that were published before the end of August 2017. Conclusively, Scientists are utilizing high time and resource to salvage this nemesis which is of global importance and cause health burden. Classical and novel biomarkers are important for treatment as well as pre- and post-diagnosis of GC. Major causes for GC are cigarette smoking, infection by Helicobacter pylori, atrophic gastritis, sex/gender, and high salt intake. Early diagnoses of GC is important for the management, treatment, pathological diagnoses by stage prognosis and metastatic setting; although the treatment outcome proved to be not much fruitful following chemotherapy, and oral medication with oxaliplatin, capecitabine, cisplatin and 5-fluorouracil (5-FU). More research studies and exploring the practical usage of gastric cancer biomarkers in diagnosis, prognosis and pre- and post-chemotherapy in clinical practice for countering gastric cancers would alleviate to some extent the ill health sufferings of humans being caused by this important and common cancerous condition.
引用
收藏
页码:1082 / 1090
页数:9
相关论文
共 149 条
  • [1] Aizawa K, 1999, INT J ONCOL, V14, P85
  • [2] Akashi K, 1997, INT J CANCER, V73, P795, DOI 10.1002/(SICI)1097-0215(19971210)73:6<795::AID-IJC4>3.0.CO
  • [3] 2-Y
  • [4] The prognostic significance of p53, p27kip1, p21waf1, HER-2/neu, and ki67 proteins expression in gastric cancer:: A clinicopathological and lmmunohistochemical study of 121 Arab patients
    Al-Moundhri, MS
    Nirmala, V
    Al-Hadabi, I
    Al-Mawaly, K
    Burney, I
    Al-Nabhani, M
    Thomas, V
    Ganguly, SS
    Grant, C
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2005, 91 (04) : 243 - 252
  • [5] Prognostic value of serum and tumor tissue CA 72-4 content in gastric cancer
    Aloe, S
    D'Alessandro, R
    Spila, A
    Ferroni, P
    Basili, S
    Palmirotta, R
    Carlini, M
    Graziano, F
    Mancini, R
    Mariotti, S
    Cosimelli, M
    Roselli, M
    Guadagni, F
    [J]. INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2003, 18 (01) : 21 - 27
  • [6] c-Met expression in gastric cancer with liver metastasis
    Amemiya, H
    Kono, K
    Itakura, J
    Tang, RF
    Takahashi, A
    An, FQ
    Kamei, S
    Iizuka, H
    Fujii, H
    Matsumoto, Y
    [J]. ONCOLOGY, 2002, 63 (03) : 286 - 296
  • [7] Ashizawa T., 2005, GASTRIC CANC, V8
  • [8] Aurello P, 2009, AM SURGEON, V75, P1183
  • [9] MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004)
    Bartel, David P.
    [J]. CELL, 2007, 131 (04) : 11 - 29
  • [10] Bhatt A N., 2010, Cancer biomarkers-Current perspectives